Comprehensive metabolomics expands precision medicine for triple-negative breast cancer.
Xiao Y, Ma D, Yang YS, Yang F, Ding JH, Gong Y, Jiang L, Ge LP, Wu SY, Yu Q, Zhang Q, Bertucci F, Sun Q, Hu X, Li DQ, Shao ZM, Jiang YZ.
Xiao Y, et al.
Cell Res. 2022 May;32(5):477-490. doi: 10.1038/s41422-022-00614-0. Epub 2022 Feb 1.
Cell Res. 2022.
PMID: 35105939
Free PMC article.